BioXcel Therapeutics Inc.
0.35
-0.01 (-1.88%)
At close: Jan 15, 2025, 2:43 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -179.05M -165.76M -106.93M -82.17M -32.97M -19.27M -4.54M -2.12M -636.00K
Depreciation & Amortization 318.00K 327.00K 297.00K 188.00K 156.00K 17.00K 1K n/a n/a
Stock-Based Compensation 18.61M 17.34M 19.45M 14.61M 3.14M 3.08M 1.61M 671.00K n/a
Other Working Capital 5.07M -123.00K 130.00K -2.01M -1.19M -539.00K -1K -1K 174.00K
Other Non-Cash Items 3.10M 2.08M 46.00K 14.99M 3.45M 3.12M 1.61M 671.00K 182.00K
Deferred Income Tax n/a n/a n/a -14.99M -3.45M n/a n/a n/a n/a
Change in Working Capital 2.02M 10.67M 4.98M 1.02M 2.39M 2.66M 736.00K 155.00K 174.00K
Operating Cash Flow -155.01M -135.34M -82.15M -66.35M -27.28M -13.51M -2.20M -1.29M -280.00K
Capital Expenditures -20.00K -139.00K -445.00K -316.00K -870.00K -340.00K n/a -4.00K -1K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a -870.00K -340.00K n/a n/a n/a
Investing Cash Flow -20.00K -139.00K -445.00K -316.00K -870.00K -340.00K n/a -4.00K -1K
Debt Repayment n/a 98.60M n/a n/a n/a -371.00K 438.00K n/a n/a
Common Stock Repurchased n/a n/a n/a -9.02M n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -510.00K -2.36M 1.45M 598.00K 201.00K -615.00K 584.00K 1.30M 281.00K
Financial Cash Flow 26.52M 96.24M 102.45M 247.36M 18.01M 55.53M 3.08M 1.30M 281.00K
Net Cash Flow -128.50M -39.24M 19.85M 180.69M -10.14M 41.68M 887.00K n/a n/a
Free Cash Flow -155.03M -135.48M -82.60M -66.67M -28.15M -13.85M -2.20M -1.30M -281.00K

Create Price Alert on BTAI

Your price alert will notify you when the stock price is above 0.35.

Add to Watchlist